The Weekly Recap 2/27/26: LSI Alumni Achievements Driving Medtech and Healthtech Forward
Life Science Intelligence announces a successful week for MedTech companies within the LSI community. As part of the announcement, Avisi Technologies was highlighted, and their $10.7M Series A fundraising round led by MedVenture Partners, bringing the company’s total funding to $21.7M. The funding will support the company’s pivotal clinical trial SAPPHIRE, which received FDA IDE approval in 2025, and further development of Avisi’s pipeline, which includes novel treatments addressing the entire spectrum of glaucomatous disease.